A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-ARM, MULTI-CENTER STUDY MEASURING THE EFFICACY AND SAFETY OF PRC-063 IN ADULT ADHD PATIENTS
Clinical Trial Grant
Administered By
Psychiatry & Behavioral Sciences
Awarded By
Purdue Pharma L.P.
Start Date
June 1, 2014
End Date
May 31, 2015
Administered By
Psychiatry & Behavioral Sciences
Awarded By
Purdue Pharma L.P.
Start Date
June 1, 2014
End Date
May 31, 2015